GB9914742D0 - Therapeutic agents - Google Patents

Therapeutic agents

Info

Publication number
GB9914742D0
GB9914742D0 GBGB9914742.3A GB9914742A GB9914742D0 GB 9914742 D0 GB9914742 D0 GB 9914742D0 GB 9914742 A GB9914742 A GB 9914742A GB 9914742 D0 GB9914742 D0 GB 9914742D0
Authority
GB
United Kingdom
Prior art keywords
therapeutic agents
therapeutic
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9914742.3A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott GmbH and Co KG
Original Assignee
Knoll GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll GmbH filed Critical Knoll GmbH
Priority to GBGB9914742.3A priority Critical patent/GB9914742D0/en
Publication of GB9914742D0 publication Critical patent/GB9914742D0/en
Priority to JP2001505897A priority patent/JP2003503344A/ja
Priority to CA002376213A priority patent/CA2376213A1/en
Priority to CZ20014614A priority patent/CZ20014614A3/cs
Priority to CN00810544A priority patent/CN1365287A/zh
Priority to TR2001/03704T priority patent/TR200103704T2/xx
Priority to AU58151/00A priority patent/AU5815100A/en
Priority to IL14707800A priority patent/IL147078A0/xx
Priority to PL00352387A priority patent/PL352387A1/xx
Priority to EP00943819A priority patent/EP1189638A2/en
Priority to BR0011884-2A priority patent/BR0011884A/pt
Priority to PCT/EP2000/005544 priority patent/WO2001000187A2/en
Priority to KR1020017016577A priority patent/KR20020012293A/ko
Priority to HU0201880A priority patent/HUP0201880A3/hu
Priority to SK1882-2001A priority patent/SK18822001A3/sk
Priority to MXPA01013023A priority patent/MXPA01013023A/es
Priority to ZA200110046A priority patent/ZA200110046B/xx
Priority to BG06209A priority patent/BG106209A/xx
Priority to NO20016301A priority patent/NO20016301L/no
Priority to HK03101311.7A priority patent/HK1050476A1/zh
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB9914742.3A 1999-06-24 1999-06-24 Therapeutic agents Ceased GB9914742D0 (en)

Priority Applications (20)

Application Number Priority Date Filing Date Title
GBGB9914742.3A GB9914742D0 (en) 1999-06-24 1999-06-24 Therapeutic agents
MXPA01013023A MXPA01013023A (es) 1999-06-24 2000-06-16 Agentes terapeuticos.
PL00352387A PL352387A1 (en) 1999-06-24 2000-06-16 Pharmaceutical composition containing sibutramine and a lipase inhibitor
BR0011884-2A BR0011884A (pt) 1999-06-24 2000-06-16 Método de tratamento da obesidade e condições comórbidas em um ser humano necessitando de tal tratamento, composto da fórmula i, produto contendo o composto da fórmula i, uso do composto da fórmula i, e, composição farmacêutica
CZ20014614A CZ20014614A3 (cs) 1999-06-24 2000-06-16 Terapeutické činidlo
CN00810544A CN1365287A (zh) 1999-06-24 2000-06-16 含有西布曲明和脂酶抑制剂的药物组合物
TR2001/03704T TR200103704T2 (tr) 1999-06-24 2000-06-16 Terapötik ajanlar
AU58151/00A AU5815100A (en) 1999-06-24 2000-06-16 Therapeutic agents
IL14707800A IL147078A0 (en) 1999-06-24 2000-06-16 Therapeutic agents
JP2001505897A JP2003503344A (ja) 1999-06-24 2000-06-16 治療薬
EP00943819A EP1189638A2 (en) 1999-06-24 2000-06-16 Pharmaceutical composition containing sibutramine and a lipase inhibitor
CA002376213A CA2376213A1 (en) 1999-06-24 2000-06-16 Therapeutic agents
PCT/EP2000/005544 WO2001000187A2 (en) 1999-06-24 2000-06-16 Pharmaceutical composition containing sibutramine and a lipase inhibitor
KR1020017016577A KR20020012293A (ko) 1999-06-24 2000-06-16 치료제
HU0201880A HUP0201880A3 (en) 1999-06-24 2000-06-16 Pharmaceutical composition containing sibutramine and a lipase inhibitor
SK1882-2001A SK18822001A3 (sk) 1999-06-24 2000-06-16 Terapeutické činidlá
ZA200110046A ZA200110046B (en) 1999-06-24 2001-12-06 Therapeutic agents.
BG06209A BG106209A (en) 1999-06-24 2001-12-11 Therapeutic agents
NO20016301A NO20016301L (no) 1999-06-24 2001-12-21 Terapeutiske midler
HK03101311.7A HK1050476A1 (zh) 1999-06-24 2003-02-20 含有西布曲明和脂酶抑制劑的藥物組合物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9914742.3A GB9914742D0 (en) 1999-06-24 1999-06-24 Therapeutic agents

Publications (1)

Publication Number Publication Date
GB9914742D0 true GB9914742D0 (en) 1999-08-25

Family

ID=10855953

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9914742.3A Ceased GB9914742D0 (en) 1999-06-24 1999-06-24 Therapeutic agents

Country Status (20)

Country Link
EP (1) EP1189638A2 (pt)
JP (1) JP2003503344A (pt)
KR (1) KR20020012293A (pt)
CN (1) CN1365287A (pt)
AU (1) AU5815100A (pt)
BG (1) BG106209A (pt)
BR (1) BR0011884A (pt)
CA (1) CA2376213A1 (pt)
CZ (1) CZ20014614A3 (pt)
GB (1) GB9914742D0 (pt)
HK (1) HK1050476A1 (pt)
HU (1) HUP0201880A3 (pt)
IL (1) IL147078A0 (pt)
MX (1) MXPA01013023A (pt)
NO (1) NO20016301L (pt)
PL (1) PL352387A1 (pt)
SK (1) SK18822001A3 (pt)
TR (1) TR200103704T2 (pt)
WO (1) WO2001000187A2 (pt)
ZA (1) ZA200110046B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6399826B1 (en) * 1999-08-11 2002-06-04 Sepracor Inc. Salts of sibutramine metabolites, methods of making sibutramine metabolites and intermediates useful in the same, and methods of treating pain
US7089666B2 (en) * 2003-06-06 2006-08-15 The Regents Of The University Of California Microfabricated vertical comb actuator using plastic deformation
CN101626768B (zh) 2006-09-15 2013-08-21 雷维瓦药品公司 环烷基甲胺的合成、使用方法和组合物
CN101890017A (zh) * 2009-05-22 2010-11-24 北京奥萨医药研究中心有限公司 含有西布曲明和他汀类降脂药物的药物组合物及其用途
WO2012003501A2 (en) 2010-07-02 2012-01-05 Reviva Pharmaceuticals, Inc. Compositions, synthesis, and methods of using cycloalkylmethylamine derivatives
BR112014016122A8 (pt) 2011-12-30 2017-07-04 Reviva Pharmaceuticals Inc composto, e, composição farmacêutica

Also Published As

Publication number Publication date
CA2376213A1 (en) 2001-01-04
WO2001000187A3 (en) 2001-11-15
NO20016301D0 (no) 2001-12-21
MXPA01013023A (es) 2003-08-01
SK18822001A3 (sk) 2003-04-01
IL147078A0 (en) 2002-08-14
WO2001000187A2 (en) 2001-01-04
BG106209A (en) 2002-09-30
HUP0201880A2 (hu) 2002-12-28
EP1189638A2 (en) 2002-03-27
JP2003503344A (ja) 2003-01-28
HK1050476A1 (zh) 2003-06-27
HUP0201880A3 (en) 2003-03-28
AU5815100A (en) 2001-01-31
KR20020012293A (ko) 2002-02-15
TR200103704T2 (tr) 2002-05-21
PL352387A1 (en) 2003-08-25
NO20016301L (no) 2001-12-21
ZA200110046B (en) 2003-03-06
CN1365287A (zh) 2002-08-21
BR0011884A (pt) 2003-08-12
CZ20014614A3 (cs) 2004-02-18

Similar Documents

Publication Publication Date Title
GB9911863D0 (en) Therapeutic agents
GB9905010D0 (en) Therapeutic agents
HK1200316A1 (en) Therapeutic microfoams
IL150030A0 (en) Therapeutic agents
GB9904786D0 (en) Therapeutic agents
GB9806102D0 (en) Therapeutic agents
GB9929685D0 (en) Therapeutic agents
GB9929687D0 (en) Therapeutic agents
GB9921351D0 (en) Therapeutic agents
GB9911881D0 (en) Therapeutic agents
PL339848A1 (en) Therapeutic agent against hypephosphataemia
GB9801210D0 (en) Therapeutic agents
AP9901436A0 (en) Therapeutic agents
GB9903476D0 (en) Therapeutic agents
GB9929569D0 (en) Therapeutic agents
GB9911802D0 (en) Therapeutic combination
GB9911803D0 (en) Therapeutic combination
GB9914744D0 (en) Therapeutic agents
GB9911804D0 (en) Therapeutic combination
GB9801202D0 (en) Therapeutic agents
GB9903119D0 (en) Therapeutic agents
IL147078A0 (en) Therapeutic agents
GB9914745D0 (en) Therapeutic agents
GB9902881D0 (en) Therapeutic agents
GB9914743D0 (en) Therapeutic agents

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)